• Medicine 1

    When patients are involved, medical research results become meaningful solutions

  • Medicine 2

    We provide patient input to the latest research for chronic diseases

  • Medicine 3

    Improving patient knowledge and involvement in clinical trials

EFA at 69th WHO Regional Committee in Copenhagen
Ahead of this important meeting, EFA produced a video statement which looked into the lessons learnt from the implementation of WHO Health2020 framework in the European region. WHO’s work in 2018/19 ...

Read more

2nd Atopic Eczema Day has been a big success!
#1: AtopicalLives online photo exhibition and video Our AtopicalLives online photo gallery and video introduces eczema patients from several countries and shows their daily lives with the disease, t ...

Read more

Global Vaccination Summit
EFA attended the 1st Global Vaccination Summit, held in Brussels on 12th September. The summit was a joint organisational effort of the European Commission and the World Health Organisation (WHO). T ...

Read more

EFA response to EMA public consultation on Drug-Device Combination
In June, the European Medicines Agency (EMA) launched a public consultation on the basis of a draft guideline discussing the ‘Quality requirements for drug-device combinations’. The draft guideline pr ...

Read more

EFA at European Health Stakeholder Meeting in the European Parliament
On September 12th, EFA participated in a panel-discussion in the European Parliament on “Brexit: the European Parliaments’ role in prioritising patients, public health and health security across Europ ...

Read more

Health is In! and with more responsibility in the new European Commission
The European Commission President-elect Ursula von der Leyen announced the names and portfolios of the new college of Commissioners. The health files were handed to Stella Kyriakides from Cyprus who h ...

Read more

EFA response to HMA public consultation on allergen product development
In April, the network of Heads of Medicines Agencies in the EU (HMA) launched a public consultation on common regulatory approaches for allergen products. The consultation puts several draft recommend ...

Read more

EFA celebrates World Patient Safety Day
On September 17th, EFA has been active on the World Health Organizations’ (WHO) 1st World Patient Safety Day. The day has been set up to create awareness for patient safety and urge people for support ...

Read more

International awareness days – great opportunities for patient groups
International awareness days are an opportunity to educate the general public on specific issues. Especially for patient organisations, it is a great possibility to mobilise political will and resourc ...

Read more

Danish politicians tested for allergies
In September, EFA member Asthma and Allergy Denmark has carried out a campaign specially focussed on the lack of specialists and asking for greater capacity in healthcare for the 1.5 million people wi ...

Read more

Back to school – Being prepared with allergy
EFA member Allergy UK has collected a variety of resources for students, parents and carers to empower parents and children feeling safe in school despite having allergies, available here. The Schools ...

Read more

Food allergen regulation around the world
EFA member Dutch Food Allergies Foundation, has shared an interactive chart providing interesting information on food allergen regulation around the world. The chart can be accessed here.
Survey on the use of lay language summaries in paediatric clinical trials
The European Forum of Good Clinical Practices (EFGCP) in collaboration with the European Federation of Pharmaceutical Industries and Association (EFPIA) are working together to understand what is the  ...

Read more

Join us on the 2nd World Atopic Eczema Day on September 14th
On September 14th, EFA, together with Global Skin, is marking World Atopic Eczema Day. With the day’s theme BENEATH THE SURFACE we raise awareness and understanding of this allergic skin disease. We i ...

Read more

EFA at the Patient Access Partnership conference on the Future of Health
On 11 and 12 July, EFA was proud to contribute to the high-level conference of Patient Access Partnership (PACT) on ‘The Future of Health: Advancing the UN 2030 Sustainable Development Agenda in Europ ...

Read more

EFA response to EMA consultation on allergen product development in low-sized populations
The European Medicines Agency (EMA) launched a public consultation on the basis of a concept paper for a ‘Guideline for allergen products development in moderate to low-sized study populations’. The ...

Read more

EFA Response to EMA Public Consultation on Patient Registries
The European Medicines Agency (EMA) launched a public consultation on the basis of a discussion paper focusing on the “use of patient disease registries for regulatory purposes – methodological and op ...

Read more

EFA response to WHO invitation for public comment: Global Action Plan for Healthy Lives and Well-being
EFA provided input in the call for comments organised by the World Health Organisation (WHO), regarding strengthening collaboration among multilateral health organisations to accelerate country progre ...

Read more

Medical Devices Regulation - Guidance on graphical symbols
The Medical Devices Regulation (2017/745 EU) entered into force in 2017 with rules being applicable after a transitional period ending in spring 2020. The new regulation contains a series of important ...

Read more

EFA at EFPIA Annual Conference
EFA Director Susanna Palkonen attended the annual networking event of the European Federation of Pharmaceutical Industries Associations (EFPIA). The event was hosted by the Finnish EU Presidency. Ec ...

Read more

What's new - Medical devices

In June, the European Medicines Agency (EMA) launched a public consultation on the basis of a draft guideline discussing the ‘Quality requirements for drug-device combinations’. The draft guideline pr ...

Read more...

The Medical Devices Regulation (2017/745 EU) entered into force in 2017 with rules being applicable after a transitional period ending in spring 2020. The new regulation contains a series of important ...

Read more...

Latest research - Medical devices

In November 2016, we met in Manchester with our partners of the Horizon 2020 project myAirCoach to track the status quo in all work-packages, the main results achieved in 2016 and to plan the third an ...

Read more...

EFA organised the final event of AirPROM, an EU funded project that during five years has pulled out the best knowledge of lung research in Europe to come up with a virtual model of the human lungs. E ...

Read more...

Key Facts

500,000 medical technologies
are available to healthcare professionals

22,500
medical technology companies in Europe

8%
of sales is spent on research and development